1. Home
  2. SPXC vs RGEN Comparison

SPXC vs RGEN Comparison

Compare SPXC & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SPX Technologies Inc.

SPXC

SPX Technologies Inc.

N/A

Current Price

$168.58

Market Cap

9.7B

Sector

Industrials

ML Signal

N/A

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$163.84

Market Cap

10.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPXC
RGEN
Founded
1912
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
10.0B
IPO Year
1994
1995

Fundamental Metrics

Financial Performance
Metric
SPXC
RGEN
Price
$168.58
$163.84
Analyst Decision
Strong Buy
Buy
Analyst Count
14
22
Target Price
★ $257.36
$196.70
AVG Volume (30 Days)
580.9K
★ 1.1M
Earning Date
10-29-2026
10-27-2026
Dividend Yield
N/A
N/A
EPS Growth
18.08
★ 286.96
EPS
★ 2.73
0.24
Revenue
★ $2,265,100,000.00
$141,236,000.00
Revenue This Year
$21.71
$12.02
Revenue Next Year
$13.08
$18.03
P/E Ratio
★ $62.51
$701.19
Revenue Growth
14.17
★ 35.10
52 Week Low
$166.17
$100.99
52 Week High
$251.08
$198.87

Technical Indicators

Market Signals
Indicator
SPXC
RGEN
Relative Strength Index (RSI) 32.64 39.68
Support Level N/A $159.22
Resistance Level $247.47 $175.32
Average True Range (ATR) 5.31 8.95
MACD 0.66 -3.00
Stochastic Oscillator 11.99 11.84

Price Performance

Historical Comparison
SPXC
RGEN

About SPXC SPX Technologies Inc.

SPX Technologies Inc supplies engineered heating, ventilation, and air conditioning, or HVAC, products, as well as detection and measurement technologies and power equipment. The company operates through two reportable segments. The HVAC segment which generates the majority of the revenue for the company, designs, manufactures, installs, and services cooling products, as well as heating and ventilation products. The Detection and Measurement technologies segment designs, manufactures, and installs underground pipe and cable locators and inspection equipment, bus-fare collection systems, and others. Geographically, the company has its operations in the United States, Canada, China, the United Kingdom, and Others. It derives maximum revenue from United States.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: